All Stories

  1. Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals

    Article • Hematological Oncology, August 2018, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  2. Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma

    Article • British Journal of Haematology, April 2018, Wiley

    Dr Francesco Bertoni, Luciano Cascione, RAFFAELLA GATTA

  3. Recent advances in understanding the biology of marginal zone lymphoma

    Article • F1000Research, March 2018, Faculty of 1000, Ltd.

    Emanuele Zucca, Dr Francesco Bertoni, Prof. Emanuele Zucca

  4. TCL1A interacts with TP63 and enhances the survival of Raji Burkitt lymphoma cell line

    Article • British Journal of Haematology, October 2017, Wiley

    Dr Francesco Bertoni, Dr Francesco Paduano, Dr Francesco Paduano

  5. Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1-2 study

    Article • British Journal of Haematology, July 2017, Wiley

    Dr Francesco Bertoni, Luciano Cascione

  6. Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma

    Article • British Journal of Haematology, June 2017, Wiley

    Dr Francesco Bertoni, Luciano Cascione, Prof. Emanuele Zucca

  7. Lecture Notes: Oncology, 3rd Edition. Mark Bower and Jonathan Waxman. Wiley-Blackwell, 2016, Ebook/Paperback, 352 pp., Prices starting from 23.80 euros

    Article • Hematological Oncology, June 2017, Wiley

    Dr Francesco Bertoni

  8. Inhibition of CHK 1 and WEE 1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation

    Article • British Journal of Haematology, December 2016, Wiley

    Dr Francesco Bertoni

  9. Bayesian network data imputation with application to survival tree analysis

    Article • Computational Statistics & Data Analysis, January 2016, Elsevier

    Dr Francesco Bertoni

  10. The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical models

    Article • British Journal of Haematology, August 2015, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  11. Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma

    Article • Cancer Cell, April 2015, Elsevier

    Dr Francesco Bertoni

  12. Interaction of CDCP1 with HER2 Enhances HER2-Driven Tumorigenesis and Promotes Trastuzumab Resistance in Breast Cancer

    Article • Cell Reports, April 2015, Elsevier

    Dr Francesco Bertoni

  13. The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs

    Article • Clinical Cancer Research, January 2015, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni, Luciano Cascione, Prof. Emanuele Zucca

  14. DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features

    Article • Blood, January 2015, American Society of Hematology

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  15. Genetic lesions in diffuse large B-cell lymphomas

    Article • Annals of Oncology, January 2015, Oxford University Press (OUP)

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  16. The transcription factor ETS1 in lymphomas: friend or foe?

    Article • Leukemia & Lymphoma, January 2015, Taylor & Francis

    Dr Francesco Bertoni

  17. Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas

    Article • British Journal of Haematology, January 2015, Wiley

    Dr Francesco Bertoni

  18. Two types of BCR interactions are positively selected during leukemia development in the E -TCL1 transgenic mouse model of CLL

    Article • Blood, January 2015, American Society of Hematology

    Dr Francesco Bertoni

  19. A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation

    Article • Leukemia, December 2014, Springer Science + Business Media

    Dr Francesco Bertoni, Ph. D, MIAC Franco Fulciniti

  20. 568 The BET bromodomain inhibitor OTX015 shows synergy with several anticancer agents in preclinical models of mantle cell lymphoma (MCL) and multiple myeloma (MM)

    Article • European Journal of Cancer, November 2014, Elsevier

    Dr Francesco Bertoni

  21. Emerging Role of Infectious Etiologies in the Pathogenesis of Marginal Zone B-cell Lymphomas

    Article • Clinical Cancer Research, October 2014, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  22. PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas

    Article • Leukemia & Lymphoma, October 2014, Taylor & Francis

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  23. The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma

    Article • Leukemia, October 2014, Springer Science + Business Media

    Dr Francesco Bertoni

  24. Abstract 2766: Inhibition of Chk1 and Wee1 as a new therapeutic approach in Mantle Cell Lymphoma

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni, Luciano Cascione

  25. Abstract CT402: A phase I study of inotuzumab ozogamicin (IO) in combination with temsirolimus (T) in patients (pts) with relapsed or refractory (R/R) CD22-positive (pos) B-cell non-Hodgkin lymphomas (NHL)

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni

  26. Abstract 5528: The BET Bromodomain inhibitor OTX015 targets the NFKB, TLR and JAK/STAT pathways and shows pre-clinical activity as single agent and in combination in mature B-cell tumors

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni

  27. Abstract 2604: Characterization of the activity and the mechanism of action of the new retinoid derivative ST5589 in pre-clinical models of lymphomas: involvement of MYC and cell cycle genes

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni, Luciano Cascione

  28. Abstract 739: The MEK-inhibitor pimasertib in B-cell lymphomas: Evaluation of the pre-clinical activity as single agent or in combination and identification of biomarkers of response

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni, Luciano Cascione

  29. Abstract 5531: OTX015, a novel BET inhibitor, is a promising anticancer agent for multiple myeloma

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni

  30. Abstract 2219: STAT3 network dissection in ALK positive Anaplastic Large Cell Lymphomas

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni

  31. Clinical Implications of Phosphorylated STAT3 Expression in De Novo Diffuse Large B-cell Lymphoma

    Article • Clinical Cancer Research, August 2014, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni

  32. Physiopathogenesis of Hematological Cancer. Estela MariaNovak and Eduardo MagalhãesRego‬. Bentham Science Publishers, Sharjah, 2012, U.A.E. Ebook/Print-on-Demand, 255pp., USD 109/131

    Article • Hematological Oncology, June 2014, Wiley

    Dr Francesco Bertoni

  33. Emerging Cancer Therapeutics: Lymphomas. John Sweetenham(guest editor). Demos Medical Publishing, 2012, New York, NY, USA. Hardcover edition, 389 pp., USD 85.00

    Article • Hematological Oncology, March 2014, Wiley

    Dr Francesco Bertoni

  34. Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type

    Article • Seminars in Cancer Biology, February 2014, Elsevier

    Dr Francesco Bertoni

  35. MYCnetwork mutations in high-risk chronic lymphocytic leukaemia

    Article • Hematological Oncology, January 2014, Wiley

    Dr Francesco Bertoni

  36. Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia

    Article • Genes Chromosomes and Cancer, December 2013, Wiley

    Dr Francesco Bertoni

  37. Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas

    Article • British Journal of Haematology, December 2013, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  38. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation

    Article • Leukemia, December 2013, Springer Science + Business Media

    Dr Francesco Bertoni, FRANCESC SOLE

  39. Discovering Subgroups of Patients from DNA Copy Number Data Using NMF on Compacted Matrices

    Article • PLoS ONE, November 2013, PLOS

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  40. Abstract A119: The BET-bromodomain inhibitor OTX015 shows synergism with several anticancer agents in preclinical models of diffuse large B-cell lymphoma (DLBCL).

    Article • Molecular Cancer Therapeutics, November 2013, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni

  41. Abstract A219: OTX015, a bromodomain and extraterminal inhibitor, represents a novel agent for ALK positive anaplastic large cell lymphoma.

    Article • Molecular Cancer Therapeutics, November 2013, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni

  42. Abstract A129: Novel histone deacetylase inhibitors ITF-A and ITF-B exhibit efficacy in preclinical models of mature B-cell lymphomas.

    Article • Molecular Cancer Therapeutics, November 2013, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni

  43. Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma

    Article • Blood, September 2013, American Society of Hematology

    Dr Francesco Bertoni

  44. PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma

    Article • Blood, September 2013, American Society of Hematology

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  45. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

    Article • Blood, September 2013, American Society of Hematology

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  46. Toward New Treatments for Mantle-Cell Lymphoma?

    Article • New England Journal of Medicine, August 2013, New England Journal of Medicine (NEJM/MMS)

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  47. Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma

    Article • Blood, August 2013, American Society of Hematology

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  48. Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ fromde novodiffuse large B-cell lymphoma

    Article • British Journal of Haematology, August 2013, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  49. Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis

    Article • Current Opinion in Hematology, July 2013, Wolters Kluwer Health

    Dr Francesco Bertoni

  50. The changing paradigm of chronic lymphocytic leukemia management

    Article • European Journal of Internal Medicine, July 2013, Elsevier

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  51. Prognostic impact of monocyte count at presentation in mantle cell lymphoma

    Article • British Journal of Haematology, June 2013, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  52. MALT lymphoma: extranodal marginal zone B-cell lymphoma of MALT

    Article • June 2013, Future Medicine

    Dr Francesco Bertoni

  53. Genome-wide high resolution DNA profiling of hairy cell leukaemia

    Article • British Journal of Haematology, May 2013, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  54. Abstract 3853: Humanized NOD/Scid/IL2g-/- tumor grafts recapitulate primary anaplastic large cell lymphoma.

    Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni

  55. Abstract 1017: The BRD-inhibitor OTX015 affects proliferation and gene expression of cells derived from mature lymphoid neoplasms.

    Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni

  56. Risk factors of central nervous system relapse in mantle cell lymphoma

    Article • Leukemia & Lymphoma, February 2013, Taylor & Francis

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  57. Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH

    Article • Annals of Oncology, January 2013, Oxford University Press (OUP)

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  58. MALT Lymphoma (Extranodal Marginal Zone B-Cell Lymphoma)

    Article • January 2013, Springer Science + Business Media

    Dr Francesco Bertoni

  59. Genome-Wide DNA Profiling of HIV-Related B-Cell Lymphomas

    Article • January 2013, Springer Science + Business Media

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  60. Where Do We Stand in the Genomics of Lymphomas?

    Article • December 2012, Springer Science + Business Media

    Dr Francesco Bertoni

  61. Gains ofCCND3gene in ocular adnexal MALT lymphomas: an integrated analysis

    Article • British Journal of Haematology, December 2012, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  62. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

    Article • Blood, December 2012, American Society of Hematology

    Dr Francesco Bertoni, Josep Nomdedeu

  63. MGA, a suppressor ofMYC, is recurrently inactivated in high risk chronic lymphocytic leukemia

    Article • Leukemia & Lymphoma, November 2012, Taylor & Francis

    Dr Francesco Bertoni

  64. 528 The BRD-inhibitor OTX015 Shows Pre-clinical Activity in Diffuse Large B-cell Lymphoma (DLBCL)

    Article • European Journal of Cancer, November 2012, Elsevier

    Dr Francesco Bertoni

  65. Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice

    Article • British Journal of Haematology, October 2012, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  66. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development

    Article • The Journal of Experimental Medicine, August 2012, Rockefeller University Press

    Dr Francesco Bertoni

  67. Chlamydophila Psittaci Eradication With Doxycycline As First-Line Targeted Therapy for Ocular Adnexae Lymphoma: Final Results of an International Phase II Trial

    Article • Journal of Clinical Oncology, July 2012, American Society of Clinical Oncology (ASCO)

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  68. Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma

    Article • Blood, June 2012, American Society of Hematology

    Dr Francesco Bertoni

  69. Genetic alterations in systemic nodal and extranodal non-cutaneous lymphomas derived from mature T cells and natural killer cells

    Article • Cancer Science, June 2012, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  70. An Open-Label Phase 2 Study of Twice-Weekly Bortezomib and Intermittent Pegylated Liposomal Doxorubicin in Patients With Ovarian Cancer Failing Platinum-Containing Regimens

    Article • International Journal of Gynecological Cancer, June 2012, Wolters Kluwer Health

    Dr Francesco Bertoni

  71. MYD88 somatic mutations in MALT lymphomas

    Article • British Journal of Haematology, May 2012, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  72. Abstract 4575: Three-gene diagnostic classifier for ALK negative ALCL

    Article • Cancer Research, April 2012, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni

  73. Incidence, risk factors and outcome of histological transformation in follicular lymphoma

    Article • British Journal of Haematology, February 2012, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  74. A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma

    Article • Haematologica, February 2012, Ferrata Storti Foundation (Haematologica)

    Dr Francesco Bertoni

  75. Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia

    Article • Blood, February 2012, American Society of Hematology

    Dr Francesco Bertoni

  76. IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia

    Article • Journal of Translational Medicine, January 2012, Springer Science + Business Media

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  77. Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes

    Article • Haematologica, December 2011, Ferrata Storti Foundation (Haematologica)

    Dr Francesco Bertoni

  78. Absence of NOTCH1 gene mutations in MALT lymphomas

    Article • British Journal of Haematology, December 2011, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  79. Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single array

    Article • British Journal of Haematology, November 2011, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  80. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

    Article • Blood, October 2011, American Society of Hematology

    Dr Francesco Bertoni

  81. Saliva is a reliable and practical source of germline DNA for genome-wide studies in chronic lymphocytic leukemia

    Article • Leukemia Research, October 2011, Elsevier

    Dr Francesco Bertoni

  82. Alteration of BIRC3 and multiple other NF- B pathway genes in splenic marginal zone lymphoma

    Article • Blood, August 2011, American Society of Hematology

    Dr Francesco Bertoni

  83. Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma

    Article • Leukemia & Lymphoma, August 2011, Taylor & Francis

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  84. Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis

    Article • International Journal of Cancer, August 2011, Wiley

    Dr Francesco Bertoni

  85. Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia

    Article • British Journal of Haematology, July 2011, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  86. Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion

    Article • Annals of Oncology, June 2011, Oxford University Press (OUP)

    Dr Francesco Bertoni, Josep Nomdedeu, Prof. Emanuele Zucca

  87. Del(13q14.3) length matters: an integrated analysis of genomic, fluorescence in situ hybridization and clinical data in 169 chronic lymphocytic leukaemia patients with 13q deletion alone or a normal karyotype

    Article • Hematological Oncology, June 2011, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  88. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

    Article • The Journal of Experimental Medicine, June 2011, Rockefeller University Press

    Dr Francesco Bertoni

  89. Biased immunoglobulin genes rearrangement in mantle cell lymphoma: Hints to identify the normal B-cell counterpart

    Article • Clinical Oncology and Cancer Research, June 2011, Springer Science + Business Media

    Dr Francesco Bertoni

  90. Chromosome 11q23.1 is an unstable region in B-cell tumor cell lines

    Article • Leukemia Research, June 2011, Elsevier

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  91. 13q14 Deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia

    Article • Genes Chromosomes and Cancer, May 2011, Wiley

    Dr Francesco Bertoni, Dr ALESSANDRO Gozzetti

  92. Anaplastic lymphoma kinase in human cancer

    Article • April 2011

    Dr Francesco Bertoni

  93. Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

    Article • British Journal of Haematology, April 2011, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  94. Genomic profiles of MALT lymphomas: variability across anatomical sites

    Article • Haematologica, April 2011, Ferrata Storti Foundation (Haematologica)

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  95. Integrated profiling of diffuse large B‐cell lymphoma with 7q gain

    Article • British Journal of Haematology, March 2011, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  96. In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomas

    Article • Hematological Oncology, March 2011, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  97. Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome

    Article • Hematological Oncology, March 2011, Wiley

    Dr Francesco Bertoni, Josep Nomdedeu, Prof. Emanuele Zucca

  98. B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage

    Article • British Journal of Haematology, February 2011, Wiley

    Dr Francesco Bertoni

  99. Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomas

    Article • British Journal of Haematology, January 2011, Wiley

    Dr Francesco Bertoni

  100. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

    Article • Blood, January 2011, American Society of Hematology

    Dr Francesco Bertoni

  101. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

    Article • Blood, November 2010, American Society of Hematology

    Dr Francesco Bertoni, Claudio Tripodo, Prof. Emanuele Zucca

  102. Immunogenetics features and genomic lesions in splenic marginal zone lymphoma

    Article • British Journal of Haematology, September 2010, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  103. Hierarchical clustering analysis of pathologic and molecular data identifies prognostically and biologically distinct groups of colorectal carcinomas

    Article • Modern Pathology, September 2010, Springer Science + Business Media

    Dr Francesco Bertoni

  104. Syk expression patterns differ among B-cell lymphomas

    Article • Leukemia Research, September 2010, Elsevier

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  105. Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21

    Article • British Journal of Haematology, August 2010, Wiley

    Dr Francesco Bertoni, Josep Nomdedeu, Prof. Emanuele Zucca

  106. Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia

    Article • Hematological Oncology, July 2010, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  107. Treatment of gastric marginal zone lymphoma of MALT type

    Article • Expert Opinion on Pharmacotherapy, June 2010, Informa Healthcare

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  108. An integrated Bayesian analysis of LOH and copy number data

    Article • BMC Bioinformatics, June 2010, Springer Science + Business Media

    Dr Francesco Bertoni

  109. Patterns of survival of follicular lymphomas at a single institution through three decades

    Article • Leukemia & Lymphoma, June 2010, Taylor & Francis

    Dr Francesco Bertoni

  110. Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma

    Article • Haematologica, May 2010, Ferrata Storti Foundation (Haematologica)

    Dr Francesco Bertoni

  111. Non-negative matrix factorization to perform unsupervised clustering of genome wide DNA profiles in mature B cell lymphoid neoplasms

    Article • British Journal of Haematology, April 2010, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  112. Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells

    Article • International Journal of Cancer, April 2010, Wiley

    Dr Francesco Bertoni, Mariagrazia Uguccioni

  113. The clinical and biological features of a series of immunophenotypic variant of B-CLL

    Article • European Journal Of Haematology, April 2010, Wiley

    Dr Francesco Bertoni

  114. 3 Pathogenesis of ocular adnexal lymphoma

    Article • European Journal of Cancer Supplements, April 2010, Elsevier

    Dr Francesco Bertoni

  115. 57 High-resolution genomic profiling of 533 B-cell lymphomas defines distinct tumor signatures, genomic aberrations correlated with outcome and pathogenetic subgroups

    Article • European Journal of Cancer Supplements, April 2010, Elsevier

    Dr Francesco Bertoni

  116. IGHD3-3fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia

    Article • British Journal of Haematology, April 2010, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  117. Molecular and clinical features of chronic lymphocytic leukemia with stereotyped B-cell receptors in a Ukrainian cohort

    Article • Leukemia & Lymphoma, March 2010, Taylor & Francis

    Dr Francesco Bertoni

  118. Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma

    Article • British Journal of Haematology, March 2010, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  119. Expression of Mutated IGHV3-23 Genes in Chronic Lymphocytic Leukemia Identifies a Disease Subset with Peculiar Clinical and Biological Features

    Article • Clinical Cancer Research, January 2010, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  120. Serotonin Receptor 3A Expression in Normal and Neoplastic B Cells

    Article • Pathobiology, January 2010, Karger Publishers

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  121. Genome wide DNA-profiling of HIV-related B-cell lymphomas

    Article • British Journal of Haematology, January 2010, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  122. Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas

    Article • Hematological Oncology, December 2009, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  123. A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03

    Article • Hematological Oncology, September 2009, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  124. Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior

    Article • Blood, August 2009, American Society of Hematology

    Dr Francesco Bertoni

  125. A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: An integrated genomics approach reveals a wide gene dosage effect

    Article • Genes Chromosomes and Cancer, July 2009, Wiley

    Dr Francesco Bertoni

  126. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors

    Article • British Journal of Haematology, July 2009, Wiley

    Dr Francesco Bertoni, Dr ALESSANDRO Gozzetti

  127. Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome

    Article • Clinical Cancer Research, June 2009, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni, Josep Nomdedeu, Prof. Emanuele Zucca

  128. Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma

    Article • Nature, May 2009, Springer Science + Business Media

    Dr Francesco Bertoni

  129. BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome

    Article • Human Pathology, May 2009, Elsevier

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  130. The NF- B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas

    Article • Blood, March 2009, American Society of Hematology

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  131. Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type

    Article • Annals of Oncology, February 2009, Oxford University Press (OUP)

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  132. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study

    Article • British Journal of Haematology, February 2009, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  133. Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21

    Article • Leukemia, January 2009, Springer Science + Business Media

    Dr Francesco Bertoni

  134. Bayesian DNA copy number analysis

    Article • BMC Bioinformatics, January 2009, Springer Science + Business Media

    Dr Francesco Bertoni

  135. Bayesian Joint Estimation of CN and LOH Aberrations

    Article • January 2009, Springer Science + Business Media

    Dr Francesco Bertoni

  136. Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance

    Article • Journal of Translational Medicine, January 2009, Springer Science + Business Media

    Dr Francesco Bertoni

  137. Marginal Zone Lymphomas

    Article • Hematology/Oncology Clinics of North America, October 2008, Elsevier

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  138. Up-regulation of the hypoxia-inducible factor–1 transcriptional pathway in colorectal carcinomas

    Article • Human Pathology, October 2008, Elsevier

    Dr Francesco Bertoni

  139. 195 POSTER Pharmacogenomic analysis of the peripheral blood cell transcriptome in patients with advanced solid tumors treated with the mTOR inhibitor deforolimus (AP23573; MK 8669) in phase Ib studies

    Article • European Journal of Cancer Supplements, October 2008, Elsevier

    Dr Francesco Bertoni

  140. Immunoreactivity for cyclin D1 is a reliable marker of gene aberration in plasma cell myeloma but does not specify patients prognosis

    Article • Leukemia Research, October 2008, Elsevier

    Dr Francesco Bertoni

  141. Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumours

    Article • European Journal of Cancer, September 2008, Elsevier

    Dr Francesco Bertoni

  142. Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion

    Article • British Journal of Haematology, August 2008, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  143. Pathobiology and molecular basis of MALT lymphoma

    Article • July 2008, Informa Healthcare

    Dr Francesco Bertoni

  144. High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia

    Article • British Journal of Haematology, June 2008, Wiley

    Dr Francesco Bertoni

  145. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy

    Article • Annals of Oncology, January 2008, Oxford University Press (OUP)

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  146. Hematological Oncology: further ahead

    Article • Hematological Oncology, January 2008, Wiley

    Dr Francesco Bertoni

  147. The strength of T cell stimulation determines IL-7 responsiveness, secondary expansion, and lineage commitment of primed human CD4+IL-7Rhi T cells

    Article • European Journal of Immunology, January 2008, Wiley

    Dr Francesco Bertoni

  148. Oncogenic BARD1 Isoforms Expressed in Gynecological Cancers

    Article • Cancer Research, December 2007, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni

  149. Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas

    Article • British Journal of Haematology, August 2007, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  150. Simultaneous occurrence of peripheral T-cell lymphoma unspecified and B-cell small lymphocytic lymphoma. Report of 2 cases

    Article • Human Pathology, May 2007, Elsevier

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  151. Molecular characterization of human multiple myeloma cell lines by integrative genomics: Insights into the biology of the disease

    Article • Genes Chromosomes and Cancer, March 2007, Wiley

    Dr Francesco Bertoni

  152. Bendamustine in lymphomas: More to combine?

    Article • Leukemia & Lymphoma, January 2007, Taylor & Francis

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  153. ConcomitantMYCand microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma

    Article • Leukemia & Lymphoma, January 2007, Taylor & Francis

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  154. The cellular origin of mantle cell lymphoma

    Article • The International Journal of Biochemistry & Cell Biology, January 2007, Elsevier

    Dr Francesco Bertoni

  155. Chromosome instability and translocation t(11;18) in primary gastric marginal zone B-cell lymphoma of MALT-type

    Article • Hematological Oncology, January 2007, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  156. Low prevalence ofChlamydia psittaciin ocular adnexal lymphomas from Cuban patients

    Article • Leukemia & Lymphoma, January 2007, Taylor & Francis

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  157. Cyclin-dependent kinase inhibitor seliciclib showsin vitroactivity in diffuse large B-cell lymphomas

    Article • Leukemia & Lymphoma, January 2007, Taylor & Francis

    Dr Francesco Bertoni

  158. A Virtual Tissue Bank for Primary Central Nervous System Lymphomas in Immunocompetent Individuals

    Article • Pathobiology, January 2007, Karger Publishers

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  159. Integrative genomic analysis reveals distinct transcriptional and genetic features associated with chromosome 13 deletion in multiple myeloma

    Article • Haematologica, January 2007, Ferrata Storti Foundation (Haematologica)

    Dr Francesco Bertoni

  160. Chlamydia or Not Chlamydia, That Is the Question: Which Is the Microorganism Associated With MALT Lymphomas of the Ocular Adnexa?

    Article • JNCI Journal of the National Cancer Institute, October 2006, Oxford University Press (OUP)

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  161. Cellular, Molecular Consequences of Peroxisome Proliferator- Activated Receptor-δ Activation in Ovarian Cancer Cells

    Article • Neoplasia, October 2006, Elsevier

    Dr Francesco Bertoni

  162. Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas

    Article • British Journal of Haematology, July 2006, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  163. Chromosome band 6q deletion pattern in malignant lymphomas

    Article • Cancer Genetics and Cytogenetics, March 2006, Elsevier

    Dr Francesco Bertoni

  164. Update on the molecular biology of mantle cell lymphoma

    Article • Hematological Oncology, January 2006, Wiley

    Dr Francesco Bertoni

  165. Marginal Zone B-Cell Lymphomas

    Article • January 2006, Elsevier

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  166. Delving deeper into MALT lymphoma biology

    Article • Journal of Clinical Investigation, December 2005, American Society for Clinical Investigation

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  167. Identification of T Cell-Restricted Genes, and Signatures for Different T Cell Responses, Using a Comprehensive Collection of Microarray Datasets

    Article • The Journal of Immunology, December 2005, The American Association of Immunologists

    Dr Francesco Bertoni

  168. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma

    Article • British Journal of Haematology, December 2005, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  169. State-of-the-Art Therapeutics: Marginal-Zone Lymphoma

    Article • Journal of Clinical Oncology, September 2005, American Society of Clinical Oncology (ASCO)

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  170. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells

    Article • Nature Immunology, July 2005, Springer Science + Business Media

    Dr Francesco Bertoni

  171. IgVH mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome

    Article • The Journal of Pathology, January 2005, Wiley

    Dr Francesco Bertoni

  172. Identification of a potential role forPOU2AF1 andBTG4 in the deletion of 11q23 in chronic lymphocytic leukemia

    Article • Genes Chromosomes and Cancer, January 2005, Wiley

    Dr Francesco Bertoni

  173. Mantle cell lymphoma

    Article • Current Opinion in Hematology, November 2004, Wolters Kluwer Health

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  174. 546 A novel aureolic acid antibiotic analogue has potent anti-proliferative activity and induces multiple changes in gene expression in ovarian cancer cells

    Article • European Journal of Cancer Supplements, September 2004, Elsevier

    Dr Francesco Bertoni

  175. 66 Anti-proliferative activity of a PPAR gamma agonist is associated with changes in the expression of cell cycle and apoptosis related genes in human ovarian cancer cells

    Article • European Journal of Cancer Supplements, September 2004, Elsevier

    Dr Francesco Bertoni

  176. Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research

    Article • British Journal of Haematology, January 2004, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  177. Molecular basis of mantle cell lymphoma

    Article • British Journal of Haematology, December 2003, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  178. Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia

    Article • Oncogene, January 2003, Springer Science + Business Media

    Dr Francesco Bertoni

  179. Mantle Cell Lymphoma: New Treatments Targeted to the Biology

    Article • Clinical Lymphoma, September 2002, Elsevier

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  180. The class II tumour suppressor gene RARRES3 maps to 11q12, not 11q23

    Article • Leukemia, July 2002, Springer Science + Business Media

    Dr Francesco Bertoni

  181. Genetic alterations underlying the pathogenesis of MALT lymphoma

    Article • The Hematology Journal, January 2002, Springer Science + Business Media

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  182. Application of genomic real-time PCR to characterise 11q deletions in mantle cell lymphoma and chronic lymphocytic leukaemia

    Article • European Journal of Cancer, April 2001, Elsevier

    Dr Francesco Bertoni

  183. Gastric MALT lymphomas prospective LY03 randomised cooperative trial: preliminary results of the molecular follow-up

    Article • European Journal of Cancer, April 2001, Elsevier

    Dr Francesco Bertoni

  184. Construction of a chromosome 11q22–23 BAC/PAC contig to characterize deletions in lymphoproliferative disorders

    Article • Nature Genetics, April 2001, Springer Science + Business Media

    Dr Francesco Bertoni

  185. MALT lymphoma and other marginal zone lymphomas

    Article • January 2001, Cambridge University Press

    Dr Francesco Bertoni

  186. Prognostic models for diffuse large b‐cell lymphoma

    Article • Hematological Oncology, June 2000, Wiley

    Dr Francesco Bertoni

  187. Analysis ofFas/CD95 gene somatic mutations in ovarian cancer cell lines

    Article • International Journal of Cancer, May 2000, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  188. Analysis of Fas/CD95 gene somatic mutations in ovarian cancer cell lines

    Article • International Journal of Cancer, May 2000, Wiley

    Dr Francesco Bertoni

  189. BCL10 gene mutations rarely occur in lymphoid malignancies

    Article • Leukemia, April 2000, Springer Science + Business Media

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  190. Molecular detection of circulating neoplastic cells in patients with clinically localised gastric and non-gastric mucosa-associated lymphoid tissue lymphoma

    Article • Digestive and Liver Disease, April 2000, Elsevier

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  191. Molecular analysis of low grade extranodal marginal zone B-cell lymphoma by alumorph genotyping

    Article • Gastroenterology, April 2000, Elsevier

    Dr Francesco Bertoni

  192. Association of gastric and Waldeyer's ring lymphoma: a molecular study

    Article • Hematological Oncology, March 2000, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  193. Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas

    Article • Leukemia, March 2000, Springer Science + Business Media

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  194. Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin

    Article • Human Pathology, February 2000, Elsevier

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  195. Extranodal Marginal Zone B-Cell Lymphoma Genotyping byAlu— Polymerase Chain Reaction

    Article • Leukemia & Lymphoma, January 2000, Taylor & Francis

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  196. Prognostic models for diffuse large b-cell lymphoma

    Article • Hematological Oncology, January 2000, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  197. The effect of Rituximab on patients with follicular and mantle-cell lymphoma

    Article • Annals of Oncology, January 2000, Oxford University Press (OUP)

    Dr Francesco Bertoni

  198. CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers

    Article • Genes Chromosomes and Cancer, October 1999, Wiley

    Dr Francesco Bertoni

  199. CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers

    Article • Genes Chromosomes and Cancer, October 1999, Wiley

    Dr Francesco Bertoni

  200. DNA fingerprinting of low-grade extranodal marginal zone B-cell lymphoma (of MALT type)

    Article • European Journal of Cancer, September 1999, Elsevier

    Dr Francesco Bertoni

  201. CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers

    Article • European Journal of Cancer, September 1999, Elsevier

    Dr Francesco Bertoni

  202. Molecular Genetics of Extranodal Marginal Zone (MALT-Type) B-Cell Lymphoma

    Article • Leukemia & Lymphoma, January 1999, Taylor & Francis

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  203. Immunoglobulin Light Chain Kappa Deletion Rearrangement as a Marker of Clonality in Mantle Cell Lymphoma

    Article • Leukemia & Lymphoma, January 1999, Taylor & Francis

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  204. Primary Mediastinal Large B-Cell Lymphoma: The Need for Prospective Controlled Clinical Trials

    Article • Leukemia & Lymphoma, January 1999, Taylor & Francis

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  205. Primary Mediastinal Large B-Cell Lymphoma (PMLCL): The Need for Prospective Controlled Clinical Trials

    Article • Leukemia & Lymphoma, January 1999, Taylor & Francis

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  206. Management of rare forms of lymphoma

    Article • Current Opinion in Oncology, September 1998, Wolters Kluwer Health

    Dr Francesco Bertoni

  207. Cardiac involvement in HIV-related non-Hodgkin's lymphoma: a case report and short review of the literature

    Article • Annals of Hematology, August 1998, Springer Science + Business Media

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  208. Primary extranodal lymphoma of skeletal muscles: a report of four cases.

    Article • Oncology Reports, May 1998, Spandidos Publications

    Dr Francesco Bertoni

  209. Molecular Analysis of the Progression from Helicobacter pylori –Associated Chronic Gastritis to Mucosa-Associated Lymphoid-Tissue Lymphoma of the Stomach

    Article • New England Journal of Medicine, March 1998, New England Journal of Medicine (NEJM/MMS)

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  210. Autoreactive B cell clones in marginal-zone B cell lymphoma (MALT lymphoma) of the stomach

    Article • Leukemia, February 1998, Springer Science + Business Media

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  211. Primary mediastinal diffuse large cell lymphoma (PMLCL): The experience of the servizio di radioterapia and the servizio oncologico cantonale, Ospedale San Giovanni Bellinzona

    Article • International Journal of Radiation Oncology*Biology*Physics, January 1998, Elsevier

    Dr Francesco Bertoni

  212. Immunoglobulin heavy chain Diversity genes rearrangement pattern indicates that MALT‐type gastric lymphoma B cells have undergone an antigen selection process

    Article • British Journal of Haematology, June 1997, Wiley

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  213. Clinical significance of bcl-2 (MBR)/JH rearrangement in the peripheral blood of patients with diffuse large B-cell lymphomas

    Article • Annals of Oncology, December 1996, Oxford University Press (OUP)

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  214. MALT and other marginal zone lymphomas

    Article • Cambridge University Press

    Dr Francesco Bertoni, Prof. Emanuele Zucca

  215. B-cell chronic lymphocytic leukemia

    Article • Cambridge University Press

    Dr Francesco Bertoni